Hormonal side effects of interferon-α therapy in children with chronic hepatitis B infection

Kaynakça (11)

1. Gisslinger H, Suobada T, Clodi M, et al. Interferon alpha stimulates the hypothalamic-pituitary-adrenal axis in vivo and in vitro. Neuroendocrinology 1993; 57: 489-95
2. Menzies R, Phelps C, Wiranowska M, et al. The effect of interferon- alpha on the pituitary-adrenal axis. J Interferon Cytokin Res 1996; 16: 619-29
3. Fernandez-Soto L, Gonzales A, Escobar-Jimenez F, et al. Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy. Arch Intern Med 1998; 158: 1445-8
4. Custro N, Montalto G, Scafidi V, et al. Prospective study on thyroid autoimmunity and dysfunction related to chronic hepatitis C and interferon therapy. J Endocrinol Invest 1997; 20: 374-80
5. Liberek A, Luczak G, Korzon M, et al. Tolerance of interferon- alpha therapy in children with chronic hepatitis B. J Paediatr Child Health 2004; 40: 265-9
6. Vankelecom H, Carmeliet P, Heremans H, et al. Interferongamma inhibits stimulated adrenocorticotropin, prolactin, and growth hormone secretion in normal rat anterior pituitary cell cultures. Endocrinology 1990; 126: 2919-26
7. Hofland LJ, de Herder WW, Waaijers M, et al. Interferon alpha 2-a is a potent inhibitor of hormone secretion by cultured human pituitary adenomas. J Clin Endocrinol Metab 1999; 84: 1336-43
8. Doi F, Kakizaki S, Takagi H, et al. Long-term outcome of interferon-alpha-induced autoimmune thyroid disorders in chronic hepatitis C. Liver Int 2005; 25: 242-6
9. Kansu A, Kuloglu Z, Demirceken F, et al. Autoantibodies in children with chronic hepatitis B infection and the influence of interferon alpha. Turk J Gastroenterol 2004; 15: 213- 8
10. Martin-Vivaldi R, Nogueras F, Quintero D, et al. Thyroid dysfunction in patients with chronic hepatitis C pre and posttreatment via interferon. Rev Esp Enferm Dig 1996; 88: 480-4
11. Iorio R, Pensati P, Botta S, et al. Side effects of alpha-interferon therapy and impact on health-related quality of life in children with chronic viral hepatitis. Pediatr Infect Dis J 1997; 16: 984-90.